Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 2,246,387	$ 3,258,058
Prepaid expenses and other current assets	750,333	564,645
Inventories	4,159,496	3,713,215
Advances on contracts	943,740	1,275,260
Total current assets	8,624,926	9,286,554
Furniture, fixtures and equipment, net	12,240	12,921
Intangibles, net	130,949	148,404
Right of use assets finance lease	63,784	67,201
Right of use assets operating lease	231,967	257,842
Other assets	24,150	24,150
Total assets	9,088,016	9,797,072
Current liabilities:
Accrued expenses and other payables	1,315,937	1,796,319
Accrued expenses, related party	311,741	304,293
Current portion of finance lease liabilities	17,086	12,530
Current portion of operating lease liabilities	119,680	116,279
Total current liabilities	4,443,633	3,744,127
Non-current portion of finance lease liabilities	47,838	54,672
Non-current portion of operating lease liabilities	134,093	165,573
Total liabilities	4,625,564	3,964,372
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 100,000,000 shares; 78,230,382 shares issued and 78,197,049 shares outstanding as of March 31, 2025; 78,047,798 shares issued and 78,014,465 shares outstanding as of December 31, 2024;	78,230	78,048
Additional paid in capital	135,343,430	134,719,274
Accumulated deficit	(130,047,692)	(128,053,106)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	4,462,452	5,832,700
Total liabilities and stockholders’ equity	9,088,016	9,797,072
Nonrelated Party [Member]
Current assets:
Accounts receivable, net of allowance for credit losses of $10,000, respectively	518,547	475,376
Current liabilities:
Accounts payable	1,918,301	1,021,393
Related Party [Member]
Current assets:
Accounts receivable, related party net	6,423	0
Current liabilities:
Accounts payable	$ 760,888	$ 493,313